BMI's Q2 sales rise 10% on utility water strength and SmartCover synergies, even as EPS misses expectations.

FTAI's Q2 earnings are likely to have surged on robust growth in engine leasing and aircraft leasing sales.

OKLO stock's 551% surge contrasts sharply with its zero revenue and slow regulatory progress.

TDY posts strong Q2 with double-digit sales growth and beats on EPS, powered by gains across all business segments.

PCAR beats Q2 earnings estimates despite lower truck sales, as Parts and Financial segments outperform projections.

Synovus Financial Corp. (SNV) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, SNV's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

The mean of analysts' price targets for Soleno Therapeutics (SLNO) points to a 33.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 26.9% in Array Technologies (ARRY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

After reaching an important support level, Anywhere Real Estate Inc. (HOUS) could be a good stock pick from a technical perspective. HOUS recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

The mean of analysts' price targets for Helios Technologies (HLIO) points to a 27.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The consensus price target hints at a 25.7% upside potential for Iamgold (IAG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

After reaching an important support level, GXO Logistics, Inc. (GXO) could be a good stock pick from a technical perspective. GXO recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

From a technical perspective, FIGS, Inc. (FIGS) is looking like an interesting pick, as it just reached a key level of support. FIGS's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.

The consensus price target hints at a 56.9% upside potential for Controladora Vuela (VLRS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

From a technical perspective, Arista Networks, Inc. (ANET) is looking like an interesting pick, as it just reached a key level of support. ANET's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.

Toymaker Hasbro Inc (NASDAQ:HAS) is moving 2.7% lower to trade at $75.49, despite posting a notable second-quarter earnings and revenue beat.

CALABASAS, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- In a press release issued earlier today by NeOnc Technologies Holdings, Inc. under the headline, "NeOnc Technologies' Executive Chairman to Be Featured in Live Interview with Kenny Polcari on YouTube.com/@Floorstocks — Today at 11:00 a.m. ET," please note "today" in the headline and first paragraph should be "July 24, 2025." The corrected release follows:

RADNOR, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS) on behalf of those who purchased or otherwise acquired Hims & Hers securities between April 29, 2025, and June 23, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is August 25, 2025.

AMGN's deep pipeline and rare disease expansion may outweigh NVO's GLP-1 dominance and leadership shakeup.

V is likely positioned for another earnings beat as digital payments surge and volumes rise in fiscal Q3.